Detalhe da pesquisa
1.
Chimpanzee Adenovirus Vector Ebola Vaccine.
N Engl J Med
; 376(10): 928-938, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25426834
2.
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.
N Engl J Med
; 374(17): 1635-46, 2016 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25629663
3.
Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.
J Urban Health
; 95(1): 99-110, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29204843
4.
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants.
Mol Ther
; 25(2): 547-559, 2017 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153101
5.
Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Hepatology
; 63(5): 1442-54, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26513111
6.
Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.
Hepatology
; 63(5): 1455-70, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26474390
7.
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants.
Mol Ther
; 24(8): 1470-7, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27109630
8.
Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice.
Gut
; 65(12): 2029-2034, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26306759
9.
Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.
J Gen Virol
; 97(1): 82-94, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26519290
10.
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.
J Infect Dis
; 211(7): 1076-86, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25336730
11.
Dramatic potentiation of the antiviral activity of HIV antibodies by cholesterol conjugation.
J Biol Chem
; 289(50): 35015-28, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25342747
12.
Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model.
J Antimicrob Chemother
; 70(6): 1784-7, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25656410
13.
Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.
J Virol
; 88(10): 5502-10, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24599994
14.
T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.
Hepatology
; 60(5): 1531-40, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24975498
15.
Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.
Hepatology
; 60(5): 1508-18, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24797654
16.
Cholesterol conjugation potentiates the antiviral activity of an HIV immunoadhesin.
J Pept Sci
; 21(9): 743-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26292842
17.
Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and chimpanzee-derived recombinant adenoviral vector immunization.
J Immunol
; 190(6): 2720-35, 2013 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23390298
18.
Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.
Mol Ther
; 22(5): 1039-47, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24476798
19.
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations.
Mol Ther
; 22(11): 1992-2003, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24930599
20.
A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.
Hepatology
; 55(2): 364-72, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21953761